BioLineRx Ltd. (TLV:BLRX)
1.700
-0.100 (-5.56%)
At close: Dec 4, 2025
BioLineRx Revenue
BioLineRx had revenue of $427.00K USD in the quarter ending September 30, 2025, a decrease of -91.36%. This brings the company's revenue in the last twelve months to $12.74M, down -42.09% year-over-year. In the year 2024, BioLineRx had annual revenue of $28.94M with 502.92% growth.
Revenue (ttm)
$12.74M
Revenue Growth
-42.09%
P/S Ratio
1.05
Revenue / Employee
$454.82K
Employees
28
Market Cap
44.38M ILS
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| Kamada | 578.74M |
| BrainsWay | 162.56M |
| Bait Bakfar | 107.78M |
| SofWave Medical | 255.13M |
| Ilex Medical | 915.05M |
| Novolog (Pharm-Up 1966) | 1.97B |
BioLineRx News
- 11 days ago - BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - BioLineRx (BLRX) Surpasses Q3 EPS Estimates Despite Revenue Shortfall - GuruFocus
- 11 days ago - BioLineRx (BLRX) Q3 Revenue Declines Amid New Joint Venture - GuruFocus
- 11 days ago - BioLineRx GAAP EPS of $0.00 beats by $0.54, revenue of $0.43M misses by $0.24M - Seeking Alpha
- 11 days ago - BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 11 days ago - Earnings Scheduled For November 24, 2025 - Benzinga
- 14 days ago - BioLine Rx's Earnings: A Preview - Benzinga
- 14 days ago - BioLineRx Q3 2025 Earnings Preview - Seeking Alpha